These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25172764)

  • 1. Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.
    Rivard C; Geller M; Schnettler E; Saluja M; Vogel RI; Saluja A; Ramakrishnan S
    Gynecol Oncol; 2014 Nov; 135(2):318-24. PubMed ID: 25172764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
    Arora N; Alsaied O; Dauer P; Majumder K; Modi S; Giri B; Dudeja V; Banerjee S; Von Hoff D; Saluja A
    PLoS One; 2017; 12(2):e0171827. PubMed ID: 28192510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.
    Modi S; Kir D; Giri B; Majumder K; Arora N; Dudeja V; Banerjee S; Saluja AK
    J Gastrointest Surg; 2016 Jan; 20(1):13-23; discussion 23-4. PubMed ID: 26503259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
    Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
    FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
    Chugh R; Sangwan V; Patil SP; Dudeja V; Dawra RK; Banerjee S; Schumacher RJ; Blazar BR; Georg GI; Vickers SM; Saluja AK
    Sci Transl Med; 2012 Oct; 4(156):156ra139. PubMed ID: 23076356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
    Isharwal S; Modi S; Arora N; Uhlrich C; Giri B; Barlass U; Soubra A; Chugh R; Dehm SM; Dudeja V; Saluja A; Banerjee S; Konety B
    Prostate; 2017 May; 77(6):584-596. PubMed ID: 28144973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.
    Rousalova I; Banerjee S; Sangwan V; Evenson K; McCauley JA; Kratzke R; Vickers SM; Saluja A; D'Cunha J
    PLoS One; 2013; 8(10):e77411. PubMed ID: 24143232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer.
    Modi S; Giri B; Gupta VK; Lavania S; Sethi V; Sharma NS; Pandey S; Vickers S; Dudeja V; Saluja AK
    Cancer Lett; 2022 Jul; 537():215591. PubMed ID: 35398530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
    Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
    Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
    Hu H; Huang G; Wang H; Li X; Wang X; Feng Y; Tan B; Chen T
    Oncol Rep; 2018 Mar; 39(3):1191-1196. PubMed ID: 29286149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minnelide exhibits antileukemic activity by targeting the Ars2/miR-190a-3p axis.
    Yuan L; Jiang X; Jia G; Li Z; Wang M; Hu S; Yang J; Liang F; Zhang F; Gao L; Gao N
    Phytomedicine; 2024 Jul; 130():155724. PubMed ID: 38759317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
    Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.
    Banerjee S; Modi S; McGinn O; Zhao X; Dudeja V; Ramakrishnan S; Saluja AK
    Clin Cancer Res; 2016 Jan; 22(2):415-25. PubMed ID: 26405195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minnelide reduces tumor burden in preclinical models of osteosarcoma.
    Banerjee S; Thayanithy V; Sangwan V; Mackenzie TN; Saluja AK; Subramanian S
    Cancer Lett; 2013 Jul; 335(2):412-20. PubMed ID: 23499892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
    Westfall SD; Nilsson EE; Skinner MK
    Chemotherapy; 2008; 54(1):67-76. PubMed ID: 18073474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models.
    Rodriguez-Blanco J; Salvador AD; Suter RK; Swiderska-Syn M; Palomo-Caturla I; Kliebe V; Shahani P; Peterson K; Turos-Cabal M; Vieira ME; Wynn DT; Howell AJ; Yang F; Ban Y; McCrea HJ; Zindy F; Danis E; Vibhakar R; Jermakowicz A; Martin V; Coss CC; Harris BT; de Cubas A; Chen XS; Barnoud T; Roussel MF; Ayad NG; Robbins DJ
    J Clin Invest; 2024 Jun; 134(15):. PubMed ID: 38885332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells.
    Liu H; Shen M; Zhao D; Ru D; Duan Y; Ding C; Li H
    Biomed Res Int; 2019; 2019():2595801. PubMed ID: 31240207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
    Scalici JM; Harrer C; Allen A; Jazaeri A; Atkins KA; McLachlan KR; Slack-Davis JK
    Gynecol Oncol; 2014 Feb; 132(2):455-61. PubMed ID: 24378876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.
    Alsaied OA; Sangwan V; Banerjee S; Krosch TC; Chugh R; Saluja A; Vickers SM; Jensen EH
    Surgery; 2014 Aug; 156(2):270-9. PubMed ID: 24953273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
    Giri B; Gupta VK; Yaffe B; Modi S; Roy P; Sethi V; Lavania SP; Vickers SM; Dudeja V; Banerjee S; Watts J; Saluja A
    J Transl Med; 2019 May; 17(1):163. PubMed ID: 31109340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.